Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis

Rheumatoid Arthritis Clinical Trial

Official title:

Lifestyle Interventions Based on the Mediterranean Diet for Patients With Rheumatoid Arthritis: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02028624
• Other study ID #: RASt
• Status: Completed
• Phase: N/A
• First received: January 1, 2014
• Last updated: January 4, 2014
• Start date: September 2009
• Est. completion date: July 2011

Study information

• Verified date: January 2014
• Source: Harokopio University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Greece: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

Aim of the present study was to evaluate the effect of different lifestyle intervention administrations, in increasing adherence to the Mediterranean diet in a group of patients with RA living in the Mediterranean basin, and, thus, in improving parameters related to subjective and objective disease markers, including plasma adiponectin concentrations.

Description:

The effect of various dietary regimens and nutrient supplementation on rheumatoid arthritis (RA) has been previously explored, with the majority of the evidence supporting the beneficial effect of n-3 polyunsaturated fatty acids (PUFAs), consumed mainly as fish oil supplements. However, many capsules should be taken on a daily basis (10 - 15) in order to improve health status, increasing, thus, the high drug burden these patients may encounter; inability to comply with supplementation, as depicted in drop-out rates and adverse reactions, is also of concern. On the other hand, the so far investigation of specific dietary patterns, namely elemental or vegetarian diets, revealed similar limitations regarding inability to comply, without producing clear benefit.

The last decade, a traditional dietary pattern, the Mediterranean diet, has also been investigated in patients with RA. This pattern is characterized by abundance of plant foods (fruits, mainly as typical daily desserts, vegetables, bread, other forms of cereals, beans, nuts, and seeds), olive oil as the principal source of fat, moderate amounts of dairy products (mainly cheese and yogurt), low to moderate amounts of fish and poultry, red meat in low amounts and wine consumed in moderation, normally with meals. Adherence to the Mediterranean diet has been associated with a significant reduction in total mortality and improvement in longevity, as well as with lower incidence of atherosclerosis, coronary heart disease, metabolic syndrome and biochemical markers related to insulin resistance and inflammation. In RA, in specific, it has been shown to improve objective and subjective measures. It is also worth mentioning that this type of intervention produced negligible or no adverse effects or drop-out in RA patients. However, it has been implemented in North-European populations with a background diet far away from the Mediterranean dietary habits. It would be interesting to study the effect of a Mediterranean diet-based intervention in a Mediterranean population of RA patients, evaluate their adherence and changes in subjective disease measures as well as in biochemical markers. One of the markers of interest is adiponectin, a large 30-kDa protein produced mainly by adipocytes, sharing strong homologies with TNF and the complement factor C1q. Plasma levels of adiponectin have been negatively associated with indices of obesity, insulin resistance and cardiovascular disease. However, its role in RA is still controversial with some evidence indicating a proinflammatory effect and some other suggesting antiinflammatory properties of this adipocytokine.

Aim of the present study was to evaluate the effect of different lifestyle intervention administrations, in increasing adherence to the Mediterranean diet in a group of patients with RA living in the Mediterranean basin, and, thus, in improving parameters related to subjective and objective disease markers, including plasma adiponectin concentrations.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 48
• Est. completion date: July 2011
• Est. primary completion date: July 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• adults

• rheumatoid arthritis diagnosis according to the 1987 criteria of the American College of Rheumatology

• clinically non active disease, as assessed and documented by the patient's own rheumatology specialist

Exclusion Criteria:

• being on a slimming or any other special diet during the previous year, or being diagnosed with other serious medical conditions

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Rheumatoid Arthritis

Intervention

Behavioral:
• Nutrition counseling
Patients received nutrition counseling, through one-to-one sessions conducted once a month, until the 6-month evaluation. Nutrition counseling was based on goal-setting and aimed at increasing adherence to Mediterannean diet.

Locations

Country	Name	City	State
Greece	Euroclinic Private Hopsital	Athens
Greece	Laiko General Hospital	Athens

Sponsors (2)

Lead Sponsor	Collaborator
Harokopio University	State Scholarships Foundation, Athens, Greece

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline Mediterranean Diet Score at 6 months		6 months	No
Primary	Change from baseline Disease Activity Score (DAS28) at 6 months		6 months	No
Primary	Change from baseline Health Assessment Questionnaire (HAQ) Score at 6 months		6 months	No
Primary	Change from baseline Short Form-36 Health Survey (SF-36) score at 6 months		6 months	No
Primary	Change from baseline energy intake at 6 months		6 months	No
Primary	Change from baseline in macronutrients intake at 6 months		6 months	No
Primary	Age		baseline	No
Primary	Height		baseline	No
Primary	Change from baseline body weight at 6 months		6 months	No
Primary	Change from baseline systolic blood pressure at 6 months		6 months	No
Primary	Change from baseline plasma adiponectin concentrations at 6 months		6 months	No
Primary	Change from baseline plasma glucose levels at 6 months		6 months	No
Primary	Change from baseline serum triglycerides levels at 6 months		6 months	No
Primary	Change from baseline plasma HDL-cholesterol levels at 6 months		6 months	No
Primary	Years of education		baseline	No
Primary	Change from baseline diastolic blood pressure at 6 months		6 months	No